| [1] | Wikipedia contributors. (2023, July 10). Human papillomavirus infection. In Wikipedia, The Free Encyclopedia. Retrieved 04:51, August 28, 2023, from . |
| |
| [2] | HPV and cancer. (2023). Last Accessed: August 10, 2023 |
| |
| [3] | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses. Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 90.) 1, Human Papillomavirus (HPV) Infection. Available from: . |
| |
| [4] | Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health. 2010 Apr; 46(4 Suppl): S20-6. |
| |
| [5] | Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine. 2008 Aug 19; 26 Suppl 12: M43-52. |
| |
| [6] | Arora R, Pandhi D, Mishra K, Bhattacharya SN, Yhome VA. Anal cytology and p16 immunostaining for screening anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men: a cross-sectional study. Int J STD AIDS. 2014 Sep; 25(10): 726-33. |
| |
| [7] | Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020 Sep; 70(5): 321-346. |
| |
| [8] | Shetty S, Shetty V, Badiger S, Shetty AK. An exploratory study of undergraduate healthcare student perspectives regarding human papillomavirus and vaccine intent in India. Women’s Health. 2021; 17. |
| |
| [9] | Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012 Jan; 33(1): 7-12. |
| |
| [10] | Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health. 2015 Apr 16; 7: 405-14. |
| |
| [11] | Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2021 Jan 20; 8: 552028. |
| |
| [12] | Human papillomavirus vaccines: WHO position paper, December 2022. Last Accessed: August 14, 2023. |
| |
| [13] | Aoki ES, Yin R, Li K, Bhatla N, Singhal S, Ocviyanti D, Saika K, Suh M, Kim M, Termrungruanglert W. National screening programs for cervical cancer in Asian countries. J Gynecol Oncol. 2020 May; 31(3): e55. |
| |
| [14] | Holroyd TA, Yan SD, Srivastava V, et al. Designing a Pro-Equity HPV Vaccine Delivery Program for Girls Who Have Dropped Out of School: Community Perspectives From Uttar Pradesh, India. Health Promot Pract. 2022 Nov; 23(6): 1039-1049. |
| |
| [15] | National Cancer Institute. Human Papillomavirus (HPV) Vaccines. (2021). https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet Last accessed: August 28, 2023. |
| |
| [16] | de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010 Nov; 11(11): 1048-56. |
| |
| [17] | https://www.who.int/news-room/fact-sheets/detail/cervical-cancer#:~:text=HPV and cervical cancer&text=More than 90%25 of the,be attributed to HPV infection. |
| |
| [18] | McGraw SL, Ferrante JM. Update on prevention and screening of cervical cancer. World J Clin Oncol. 2014 Oct 10; 5(4): 744-52. |
| |
| [19] | Singh M, Jha RP, Shri N, Bhattacharyya K, Patel P, Dhamnetiya D. Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study. BMC Cancer. 2022 Feb 7; 22(1): 149. |
| |
| [20] | https://www.who.int/initiatives/cervical-cancer-elimination-initiative. |
| |
| [21] | WHO: Cervical cancer. (2022). Last accessed: August 28, 2023. |
| |
| [22] | Roden RBS, Stern PL. Opportunities and challenges for human papillomavirus vaccination in cancer. Nat Rev Cancer. 2018 Apr; 18(4): 240-254. |
| |
| [23] | Lehoux M, D' Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics. 2009; 12(5-6): 268-80. |
| |
| [24] | Groves IJ, Coleman N. Pathogenesis of human papillomavirus-associated mucosal disease. J Pathol. 2015 Mar; 235(4): 527-38. |
| |
| [25] | Ashique, S., Hussain, A., Fatima, N. et al. HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective. VirusDis. 34, 172–190 (2023). |
| |
| [26] | Bordignon V, Di Domenico EG, Trento E, D'Agosto G, Cavallo I, Pontone M, Pimpinelli F, Mariani L, Ensoli F. How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery. Viruses. 2017 Dec 19; 9(12): 390. |
| |
| [27] | Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis. 2018 Feb; 18(2): 198-206. |
| |
| [28] | Ramavath, K.K., Olyai, R. Knowledge and Awareness of HPV Infection and Vaccination Among Urban Adolescents in India: A Cross-Sectional Study. J Obstet Gynecol India 63, 399–404 (2013). |
| |
| [29] | Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021 Feb; 9(2): e161-e169. |
| |
| [30] | Valentine K, Vanden Broeck D, Benoy I, Truyens M, Bogers J. Cytology at the Time of HPV: Some Things to Think about when Discussing HPV. Acta Cytol. 2016; 60(6): 527-533. |
| |
| [31] | Khanna D, Khargekar N, Budukh A. Knowledge, attitude, and practice about cervical cancer and its screening among community healthcare workers of Varanasi district, Uttar Pradesh, India. J Family Med Prim Care. 2019 May; 8(5): 1715-1719. |
| |
| [32] | Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, Befano B, Perkins RB, He X, Dallal C, Chen J, Poitras N, Mayrand MH, Coutlee F, Burk RD, Lorey T, Castle PE, Wentzensen N, Schiffman M. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine. 2020 Apr 25; 22: 100293. |
| |
| [33] | Gamboa-Hoil SI. Human papillomavirus in men. Rev Int Androl. 2023 Jan-Mar; 21(1): 100325. |
| |
| [34] | Stern PL, van der Burg SH, Hampson IN, Broker TR, Fiander A, Lacey CJ, Kitchener HC, Einstein MH. Therapy of human papillomavirus-related disease. Vaccine. 2012 Nov 20; 30 Suppl 5(0 5): F71-82. |
| |
| [35] | https://www.webmd.com/sexual-conditions/hpv-genital-warts/hpv-treatment-is-there-hpv-cure. |
| |
| [36] | Stern PL, van der Burg SH, Hampson IN, Broker TR, Fiander A, Lacey CJ, Kitchener HC, Einstein MH. Therapy of human papillomavirus-related disease. Vaccine. 2012 Nov 20;30 Suppl 5(0 5): F71-82. |
| |
| [37] | Schiffman M, Mirabello L, Egemen D, et al. The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma. Gynecol Oncol. 2023 Jul; 174: 253-261. |
| |
| [38] | Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: Status & current concepts. Indian J Med Res. 2018 Dec; 148(6): 687-696. |
| |
| [39] | Bruni L, Saura-Lázaro A, Montoliu A, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Prev Med. 2021 Mar; 144: 106399. |
| |
| [40] | Watson M, Benard V, King J, Crawford A, Saraiya M. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey. Prev Med. 2017 Jul; 100: 243-247. |
| |
| [41] | Saraiya M, Steben M, Watson M, Markowitz L. Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians. Prev Med. 2013 Nov; 57(5): 426-33. |
| |
| [42] | Plotzker RE, Vaidya A, Pokharel U, Stier EA. Sexually Transmitted Human Papillomavirus: Update in Epidemiology, Prevention, and Management. Infect Dis Clin North Am. 2023 Jun; 37(2): 289-310. |
| |
| [43] | Burki TK. India rolls out HPV vaccination. Lancet Oncol. 2023 Apr; 24(4): e147. |
| |
| [44] | Jacob M, Mawar N, Menezes L. Assessing the Environment for Introduction of Human Papillomavirus Vaccine in India. The Open Vaccine Journal, 2010, 3: 96-107. |
| |
| [45] | Kamath A, Yadav A, Baghel J, Mundle S. Level of Awareness About HPV Infection and Vaccine Among the Medical Students: A Comprehensive Review from India. Indian J Gynecol Oncology 19, 61 (2021). |
| |
| [46] | Elbasha EH, Dasbach EJ. Impact of vaccinating boys and men against HPV in the United States. Vaccine. 2010 Oct 4; 28(42): 6858-67. |
| |
| [47] | Administering HPV Vaccine. (2021). . Last Accessed: August 14, 2023. |
| |
| [48] | Cervarix: Last Accessed: August 14, 2023. |
| |
| [49] | CERVAVAC®. Last Accessed: August 14, 2023. |
| |
| [50] | Chu K, Bi ZF, Huang WJ, Li YF, Zhang L, Yang CL, Jiang HM, Zang X, Chen Q, Liu DL, Pan HX, Huang Y, Zheng FZ, Zhang QF, Sun G, Su YY, Huang SJ, Pan HR, Wu T, Hu YM, Zhang J, Zhu FC, Xia NS. Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial. Lancet Reg Health West Pac. 2023 Mar 13; 34: 100731. |
| |
| [51] | Li M, Zhao C, Zhao Y, Li J, Wei L. Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China. Front Immunol. 2023 Mar 13; 14: 1112750. |
| |
| [52] | Krokidi E, Rao AP, Ambrosino E and Thomas PPM.The impact of health education interventions on HPV vaccination uptake, awareness, and acceptance among people under 30 years old in India: a literature review with systematic search. Front. Reprod. Health 2023; 5: 1151179. |
| |
| [53] | Balaji M, Panwar A, Kudva MA, Ballal NV, Keluskar V. Awareness and Knowledge Among Dental and Medical Undergraduate Students Regarding Human Papilloma Virus and Its Available Preventive Measures. Ann Glob Health. 2020 Nov 25; 86(1): 150. |
| |
| [54] | Rural population (% of total population). (2023). . Last accessed: August 28, 2023. |
| |
| [55] | Waller J, Marlow LA, Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev. 2006 Jul; 15(7): 1257-61. |
| |
| [56] | Herman R, McNutt LA, Mehta M, Salmon DA, Bednarczyk RA, Shaw J. Vaccination perspectives among adolescents and their desired role in the decision-making process. Hum Vaccin Immunother. 2019; 15(7-8): 1752-1759. |
| |
| [57] | Thanasas I, Lavranos G, Gkogkou P, Paraskevis D. The Effect of Health Education on Adolescents' Awareness of HPV Infections and Attitudes towards HPV Vaccination in Greece. Int J Environ Res Public Health. 2022 Jan 3; 19(1): 503. |
| |
| [58] | Saha A, Chaudhury AN, Bhowmik P, Chatterjee R. Awareness of cervical cancer among female students of premier colleges in Kolkata, India. Asian Pac J Cancer Prev. 2010; 11(4): 1085-90. PMID: 21133629. |
| |
| [59] | Rani U, Darabaner E, Seserman M, Bednarczyk RA, Shaw J. Public Education Interventions and Uptake of Human Papillomavirus Vaccine: A Systematic Review. J Public Health Manag Pract. 2022 Jan-Feb 01; 28(1): E307-E315. |
| |
| [60] | Doshi D, Srikanth Reddy B, Karunakar P, Deshpande K. HPV, cervical cancer and pap test related knowledge among a sample of female dental students in India. Asian Pacific J Cancer Prev. (2015) 16(13): 5415–20. |
| |
| [61] | ARSH (ADOLESCENT REPRODUCTIVE AND SEXUAL HEALTH). (2021). https://nhm.gujarat.gov.in/arsh1.htm. Last accessed: August 28, 2023. |
| |
| [62] | Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020 Apr; 112(2): 229-232. |
| |